WHATLEY KALLAS INVESTIGATING MONOPOLY MAINTENANCE AND PRICING FOR ADVANTIX AND ADVANTAGE FLEA MEDICATIONS
Whatley Kallas is investigating practices by Bayer, the manufacturer of Advantix- and Advantage-branded flea medications for pets, that have allowed Bayer to maintain a monopoly position over the market for veterinary topical flea medications. These practices, and Bayer’s resulting monopoly power, have caused consumers to pay at least tens of millions of dollars more for …